Amantadine Hydrochloride(SHINKEI Therapeutics)

N/A

Report date: 2025/10/24 16:19:06

Base Information

Drug NameAmantadine Hydrochloride(SHINKEI Therapeutics)
Drug Alias Nametricyclo [3.3.1.1] decan-1-amine, hydrochloride1-adamantanamine HClMR-301
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSHINKEI Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSHINKEI Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN04BB01
Related LinksN/A